fluoxetine has been researched along with ondansetron in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (23.53) | 18.2507 |
| 2000's | 11 (32.35) | 29.6817 |
| 2010's | 14 (41.18) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Jia, L; Sun, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Sen, S; Sinha, N | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jørgensen, H; Knigge, U; Warberg, J | 1 |
| Ikeda, T; Matsumoto, M; Saito, H; Tochihara, M; Togashi, H; Yoshioka, M | 1 |
| Meert, TF | 1 |
| Koriech, OM | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Bagdy, E; Harsing, LG; Solyom, S | 1 |
| Fundaró, A | 1 |
| Costall, B; Neill, JC; Wilson, AW | 1 |
| Herges, S; Taylor, DA | 1 |
| Anjaneyulu, M; Chopra, K | 1 |
| Freeman, SL; Glatzle, J; Raybould, HE; Robin, CS; Sharp, JW; Sternini, C; Valdellon, M | 1 |
| Borah, M; Radhakrishnan, M; Ramamoorthy, R | 1 |
| Limebeer, CL; Litt, DE; Parker, LA | 1 |
| Adrien, J; Escourrou, P; Real, C; Seif, I | 1 |
| Carley, DW; Herdegen, JJ; Logan, T; Olopade, C; Prasad, B; Radulovacki, M | 1 |
| Feizy, F; Malayeri, A; Motlagh, I; Sayyah, M; Siahpoosh, A; Soltani, F | 1 |
| Martin, WJ; Obedencio, GP; Shen, F; Smith, JA; Tsuruda, PR | 1 |
| Gupta, D; Kurhe, Y; Radhakrishnan, M | 1 |
| Bailey, D; Catlett, SL; Sumaya, IC | 1 |
| Khin, PP; Sohn, UD; Zaw, TS | 1 |
| Guo, D; Guo, J; Huang, S; Li, Q; Polli, JE; Shu, Y; Xiong, Z; Ye, Z; Zhang, W; Zhou, H; Zhu, P | 1 |
| Blasco-Ibañez, JM; Crespo, C; Nácher, J; Olivas-Cano, I; Rodriguez-Andreu, JM; Varea, E | 1 |
1 review(s) available for fluoxetine and ondansetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for fluoxetine and ondansetron
| Article | Year |
|---|---|
Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Ondansetron; Polysomnography; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Severity of Illness Index; Sleep Apnea, Obstructive; Treatment Outcome | 2010 |
A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder.
Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Interview, Psychological; Male; Middle Aged; Obsessive-Compulsive Disorder; Ondansetron; Outpatients; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome | 2010 |
31 other study(ies) available for fluoxetine and ondansetron
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Imidazoles; Indoles; Ketanserin; Male; Methysergide; Ondansetron; Prolactin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tropisetron | 1992 |
Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
Topics: Animals; Calcium; Fluoxetine; Hippocampus; Male; Microdialysis; Nerve Endings; Norepinephrine; Ondansetron; Potassium; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1995 |
Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Chlordiazepoxide; Citalopram; Dose-Response Relationship, Drug; Drinking; Fluoxetine; Male; Ondansetron; Rats; Receptors, Serotonin; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Fluoxetine treatment comprises the antiemetic efficacy of ondansetron in cancer patients.
Topics: Adult; Antiemetics; Binding, Competitive; Female; Fluoxetine; Humans; Male; Middle Aged; Neoplasms; Ondansetron | 1995 |
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 1997 |
Feedback stimulation of somatodendritic serotonin release: a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dendrites; Electric Stimulation; Feedback; Fluoxetine; In Vitro Techniques; Male; Neural Pathways; Ondansetron; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1998 |
Pinch-induced catalepsy in mice: a useful model to investigate antidepressant or anxiolytic drugs.
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents; Catalepsy; Female; Fluoxetine; Fluvoxamine; Imipramine; Learning; Male; Mice; Models, Psychological; Motor Activity; Ondansetron; Physical Stimulation; Reaction Time; Serotonin Antagonists; Sex Characteristics; Stereotyped Behavior | 1998 |
An investigation into the effects of 5-HT agonists and receptor antagonists on ethanol self-administration in the rat.
Topics: Animals; Buspirone; Dose-Response Relationship, Drug; Ethanol; Female; Fenfluramine; Fluoxetine; Metergoline; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Ritanserin; Selective Serotonin Reuptake Inhibitors; Self Administration; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 1998 |
Involvement of 5-HT(3) receptors in the nucleus accumbens in the potentiation of cocaine-induced behaviours in the rat.
Topics: Animals; Behavior, Animal; Cocaine; Drug Synergism; Fluoxetine; Motor Activity; Nucleus Accumbens; Ondansetron; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors | 2000 |
Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice.
Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Mice; Ondansetron; Pindolol; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Streptozocin; Time Factors; Touch | 2004 |
Ligand-induced 5-HT3 receptor internalization in enteric neurons in rat ileum.
Topics: Animals; Blotting, Western; Fluoxetine; Ileum; Immunohistochemistry; Intestinal Absorption; Intestinal Mucosa; Male; Myenteric Plexus; Neurons; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2006 |
Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Fluoxetine; Hindlimb Suspension; Male; Maze Learning; Mice; Motor Activity; Olfactory Bulb; Ondansetron; Paroxetine; Rats; Rats, Wistar; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Stress, Psychological; Venlafaxine Hydrochloride | 2008 |
Effect of 5-HT3 antagonists and a 5-HT(1A) agonist on fluoxetine-induced conditioned gaping reactions in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiemetics; Autoreceptors; Conditioning, Psychological; Dose-Response Relationship, Drug; Fluoxetine; Isoquinolines; Lithium Chloride; Male; Nausea; Ondansetron; Palonosetron; Quinuclidines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists | 2009 |
Ondansetron and fluoxetine reduce sleep apnea in mice lacking monoamine oxidase A.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Mice; Mice, Inbred C3H; Mice, Knockout; Monoamine Oxidase; Ondansetron; Plethysmography, Whole Body; Respiratory Mechanics; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep Apnea Syndromes; Wakefulness | 2009 |
Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
Topics: Analgesia; Animals; Atomoxetine Hydrochloride; Biogenic Monoamines; Chromatography, Liquid; Drug Synergism; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Morphine; Morpholines; Neurotransmitter Uptake Inhibitors; Nociceptive Pain; Norepinephrine Plasma Membrane Transport Proteins; Ondansetron; Propylamines; Rats; Rotarod Performance Test; Serotonin Plasma Membrane Transport Proteins; Tandem Mass Spectrometry; Thiophenes | 2013 |
Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.
Topics: Animals; Antidepressive Agents; Antiemetics; Anxiety; Behavior, Animal; Brain; Depression; Depressive Disorder; Diabetes Mellitus, Experimental; Exploratory Behavior; Fluoxetine; Male; Mice; Motor Activity; Ondansetron; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Streptozocin; Swimming | 2014 |
Differential effects of a short-term high-fat diet in an animal model of depression in rats treated with the 5-HT3 receptor antagonist, ondansetron, the 5-HT3 receptor agonist, 2-methyl-5-HT, and the SSRI, fluoxetine.
Topics: Animals; Depression; Diet, High-Fat; Disease Models, Animal; Fluoxetine; Male; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2016 |
Signal Transduction Underlying the Inhibitory Mechanism of Fluoxetine on Electrical Field Stimulation Response in Rat Ileal Smooth Muscle.
Topics: 4-Aminopyridine; Amides; Animals; Atropine; Azepines; Benzophenanthridines; Bicuculline; Calcimycin; Drug Interactions; Electric Stimulation; Estrenes; Fluoxetine; Glyburide; Ileum; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Ondansetron; Pyridines; Pyrrolidinones; Rats; Signal Transduction; Sulfonamides; Tetraethylammonium | 2017 |
Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Topics: Amitriptyline; Animals; Drug Interactions; Fluoxetine; HEK293 Cells; Humans; Imipramine; Irinotecan; Mice, Inbred C57BL; Morphine; Narcotics; Ondansetron; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Tissue Distribution; Verapamil | 2018 |
Fluoxetine increased adult neurogenesis is mediated by 5-HT3 receptor.
Topics: Animals; Cell Proliferation; Dentate Gyrus; Fluoxetine; Hippocampus; Neural Stem Cells; Neurogenesis; Ondansetron; Rats; Receptors, Serotonin, 5-HT3 | 2023 |